Condition
Pregnancy, Unwanted
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results33% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Terminated2
Suspended1
Completed1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02447029Phase 3CompletedPrimary
Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial
NCT04830007SuspendedPrimary
Factors Associated With the Absence of Contraception at Women Seeking a Voluntary Termination of Pregnancy
NCT03774745Phase 1TerminatedPrimary
Blocking Mifepristone Action With Progesterone
NCT03519191Not ApplicableTerminated
Healthy Relationships and Economic Pathways
Showing all 4 trials